年初至今，新药放量+Biotech逐步减亏盈利+重磅BD频出催化创新药大行情。自三生制药拿下辉瑞60亿美元BD后，再度印证了中国创新药领域在全球的竞 争力，近期整个市场都在"疯狂"挖掘下一个重磅BD。 事实上，在众多免疫系统疾病中，特应性皮炎是一种常见的高发的疾病，尤其是在儿童人群中高发，其所带来的皮肤瘙痒以及皮肤破损，严重影响患者的生 活质量。然而目前现有治疗方案无法完全达到兼顾快速止痒、皮损改善和安全性的效果。 流行病学研究显示，全球AD患者数至少2.3亿人，我国AD患者群体庞大，超过7000万人，其中中重度AD占比约达28%。对比之下，美国预计AD成人患者数 在1650万，中重度AD占比约占40%。庞大的患者群体意味着AD市场存在着巨大潜力，也推动药企加速开发差异化疗法。 6月3日，中国抗体的股价迅速拉升，盘中股价涨幅一度达到45.75%，最终收盘价2港元，收涨30.72%；6月4日，中国抗体股价继续大涨，盘中最高价触及 2.99港元，创下自2022年2月以来股价新高，后收涨42.5%，两个交易日股价涨幅高达86.27%，这也是市场预期中国抗体创新加速，押注公司未来重磅BD交 易的真实反应。 例如，安进 ...

物流装备：港机需求上行，海外新产品拓展 2023年开始全球港口设备需求修复，公司大港机在手订单饱满，订单盈利能力逐渐强化，小港机产品在 亚非拉地区的出口保持景气。过去3年公司面向欧美市场大力拓展了伸缩臂叉车等新产品，当前以印度 生产来应对关税问题。该行看好小港机电动化发展趋势，以及公司新产品在海外的持续拓展。 智通财经APP获悉，中金发布研报称，维持三一国际(00631)2025年EPS预测0.70元，引入2026年EPS预 测0.81元。公司当前股价对应2025/2026年7.9/6.7x P/E，考虑新产业盈利改善前景，该行上调目标价25% 至7.10港币，对应2025/2026年9.5x/8.1x P/E，对应21%上行空间，维持跑赢行业评级。 中金主要观点如下： 1Q25业绩符合该行预期 公司公布1Q25财务数据：收入58.76亿元，同比增长14.6%，综合毛利14.28亿元，同比增长11.8%，归母 净利润6.35亿元，同比增长23.2%，业绩符合该行预期。 矿山装备：国内需求保持韧性，看好矿车海外拓展空间 受需求偏弱影响，国内煤价处于下行通道。当前国内掘进机、宽体车需求韧性较强，液压支架价格竞争 ...

6月5日，美妆博主"大嘴博士"郝宇质疑巨子生物可复美产品的争议有了新动态。今日早间，郝宇在其公 众号发布《详细解读巨子疑点重重的检测结果》，质疑巨子生物出具"这种拼图式的嫁接报告"。并表 示，"为什么没有检测机构的名字和盖章？" 昨日晚间，巨子生物在可复美官方微博发文称，此前委托多家权威检测机构对争议产品的检测结果出 炉，可复美相关产品中真实添加重组胶原蛋白成分，不存在网传的"虚假宣传、误导消费者"行为。 巨子生物称，针对可复美 Human-like重组胶原蛋白肌御修护次抛精华（可复美胶原棒 1.0），其在四家 检测机构进行检测，结果均显示"确认产品中含有重组胶原蛋白""重组胶原蛋白含量同样大于0.1%"。 巨子生物还表示，各渠道可复美胶原棒1.0也因为售罄而陆续下架，目前部分渠道仍有库存持续销售， 不存在网传的"悄悄下架"一说。 郝宇表示，"这个检测报告打开以后，有一种开盲盒套组的感觉，没有任何一个检测机构的报告可以说 明问题，但组合起来以后，似乎又能说明自己合格了。" 他提到，"这种拼图式的嫁接报告，估计水军们也都看傻了。为什么不用一机构一方案，然后让不同的 检测机构做交叉验证，而是4家机构拼在一起凑成一 ...

Group 1 - The new consumption concept stocks in the Hong Kong market, referred to as the "three sisters," continue to show an upward trend [1] - Pop Mart (09992.HK) has increased by over 1% [1] - Old Puhuang (06181.HK) has risen by 0.6%, with its stock price surpassing 1000 HKD [1] - Mixue Group (02097.HK) opened higher [1]

2024年以来，零售药店行业在医药改革深化和消费低迷的双重压力下，进入深度调整期。行业整体增速 跌至五年低点，零售药房普遍普遍面临利润压力。近期，多家头部连锁药房透露，未来将从规模扩张转 向精细化运营，通过布局"多元化"、"新零售"、"专业化"打造差异化竞争力。政策与市场的双重压力， 促使零售药店业态加速升级。 瞄准药店业态升级趋势，院外医药数字化龙头药师帮(09885)近期也有布局动作。6月3日，药师帮宣布 与全球协作机器人头部企业越疆科技(02432)达成战略合作，以医药协作机器人、AI大模型、药品物联 网三大技术切入新零售场景，为零售药店转型提供新动能。其中，医药协作机器人应用于药品仓储、分 拣及配送环节，医药AI大模型应用于提升处方审核与用药服务效率，药品物联网技术则聚焦实现全流 程药品追溯管理。上述技术的应用，将进一步赋能零售药店，实现降本增效、服务延伸，以及药事服务 的安全性提升。 有机构观点指出，随着医药零售转型加速，自动化技术将成为药店新零售转型的核心基础设施，医药零 售行业从人力密集型向技术驱动型转变，药店服务边界与运营模式将迎来根本性变革。药师帮的数字化 优势和提前布局，将有望在行业变革中 ...

本报记者冯雨瑶刘钊 6月5日早间，重庆长安汽车股份有限公司（以下简称"长安汽车"，证券代码：000625）与东风汽车股份有限公司（以下简称"东风股份"，证券代 码：600006）分别发布公告，披露了其间接控股股东重组事项的最新进展，标志着中国汽车行业央企重组进程迈入新阶段。 长安汽车在公告中明确，其间接控股股东中国兵器装备集团有限公司（以下简称"兵器装备集团"）已获国务院批准实施分立重组。根据方案，兵器 装备集团的汽车业务将分立为一家独立中央企业，由国务院国资委直接履行出资人职责；剩余业务则注入中国兵器工业集团有限公司。此次分立 后，长安汽车的间接控股股东将变更为汽车业务分立的中央企业，但实际控制人未发生变化，公司生产经营活动不受重大影响。长安汽车表示，将 严格按照信息披露要求，持续关注重组进展并及时履行披露义务。 长安汽车董事长朱华荣此前曾公开表示，此次重组有利于公司国际化、全球化及市场化发展，将充分把握政策机遇，发挥重组带来的协同效应。尽 管重组方案已基本完成，但分立重组仍需履行法定程序，相关事项存在不确定性。 与长安汽车不同，东风股份在最新公告中明确，其间接控股股东东风汽车集团有限公司（以下简称"东风公 ...

Core Insights - Jiangnan Buyi, established in 1994, is a leading designer brand fashion company with a strong market presence and high dividend payout since its listing in 2016 [1][2] - The company has maintained a high return on equity (ROE), averaging 35.7% over the past three years and 33.4% over the past five years, positioning it among the top in the consumer goods sector [1] Group 1: Growth Strategies - The company employs three main strategies for growth: multi-brand matrix, design-driven approach, and fan-driven engagement [1] - Multi-brand matrix: Revenue contributions from mature brands, growth brands, and emerging brands are 56.2%, 41.7%, and 2.1% respectively, with compound annual growth rates (CAGR) of 9.4% and 9.2% for mature and growth brands from FY2019 to FY2024 [1] - Design-driven: The founder is directly involved in design, with strong incentives and high investment in core designers, including initiatives like the Sesame Laboratory to explore sustainable fashion [1] - Fan-driven: The company has a strong membership base with 319,000 active members contributing over 60% of offline retail sales, supported by digital retail initiatives [1] Group 2: Market Potential and Financial Outlook - The designer brand market shows significant potential, with a CAGR of 5.5% from 2017 to 2022, and an expected CAGR of 14.5% from 2023 to 2027, ranking among the top two in its segment [2] - The company has a high-quality channel presence, with 45.3% of stores located in first and second-tier cities, and a comparable store growth rate of 10.7% for FY24 [2] - Financial projections indicate revenue growth to reach 5.59 billion yuan, 5.98 billion yuan, and 6.39 billion yuan for FY2025, FY2026, and FY2027 respectively, with year-on-year growth rates of 6.7%, 7.0%, and 6.9% [2] - Net profit forecasts for the same period are 890 million yuan, 950 million yuan, and 1.02 billion yuan, with year-on-year growth rates of 4.4%, 7.6%, and 7.1% [2]

Core Viewpoint - The company's 1HFY25 performance met expectations, with revenue of 3.156 billion yuan and a net profit of 600 million yuan, reflecting year-on-year growth of 5.0% and 4.7% respectively [1] Performance Review - The company declared an interim dividend of 0.45 HKD per share, corresponding to a payout ratio of approximately 37% [1] - Revenue breakdown by channel for 1HFY25 showed a decline in direct sales by 7.7% to 1.117 billion yuan, while distribution and e-commerce channels grew by 14.2% and 11.9% to 1.437 billion yuan and 602 million yuan respectively [1] - The number of direct stores decreased by 24 to 491, while distribution stores increased by 126 to 1,614, indicating a strategic channel optimization [1] - Comparable store sales showed a modest increase of 0.1% year-on-year, indicating stability in sales performance [1] Brand Performance - Revenue from the mature brand JNBY increased by 3.6% to 1.760 billion yuan, demonstrating strong growth resilience [2] - The emerging brands saw significant growth, with revenue increasing by 147.3% to 194 million yuan, albeit from a low base [2] - Active membership accounts slightly declined to 540,000, attributed to reduced foot traffic, while high-value members (spending over 5,000 yuan) increased by 30,000 to over 330,000 [2] Cost and Profitability - The gross profit margin remained stable at 65.1%, while the selling expense ratio increased by 1.1 percentage points to 32.3% due to marketing activities for the brand's anniversary [2] - The management expense ratio rose by 0.4 percentage points to 8.6%, but government subsidies increased and the effective tax rate decreased, keeping the net profit margin stable at 19.0% [2] Development Trends - The company has been focusing on brand strength, successfully launching multiple "JNBY+" concept stores and investing in digital retail channels [2] - The company completed acquisitions of a children's clothing brand and a 100% stake in a department store brand, expanding its multi-brand portfolio [2] Earnings Forecast and Valuation - The earnings forecasts for FY25 and FY26 are maintained at 870 million yuan and 930 million yuan respectively, with the current stock price corresponding to 10 and 9 times the FY25 and FY26 earnings [3] - The target price has been raised by 16% to 20.00 HKD, reflecting an expected upside of 13% from the current stock price [3]

Core Viewpoint - Jiangnan Buyi reported a steady performance in FY2025 H1 with total revenue of 3.156 billion yuan, up 5% year-on-year, and net profit of 604 million yuan, up 5.5% year-on-year, while proposing an interim dividend of 0.45 HKD per share [1][2] Financial Performance - FY2025 H1 total revenue reached 3.156 billion yuan, with a year-on-year increase of 5% and net profit of 604 million yuan, reflecting a 5.5% year-on-year growth [1] - The overall gross margin slightly declined to 65.1%, down 0.1 percentage points year-on-year, while the net profit margin increased to 19.1%, up 0.1 percentage points year-on-year [1][2] - Revenue breakdown by brand shows JNBY at 1.76 billion yuan (up 3.6%), Sketch at 388 million yuan (down 6%), jnby by JNBY at 476 million yuan (down 0.6%), LESS at 338 million yuan (up 0.8%), and emerging brands at 194 million yuan (up 147.3%) [1] Channel Performance - Revenue by channel indicates direct sales at 1.117 billion yuan (down 7.7%), distributor channel at 1.437 billion yuan (up 14.2%), and online channel at 602 million yuan (up 11.9%) [1] - The overall expense ratio increased, with sales and marketing expenses at 32.35% (up 1.1 percentage points) and administrative expenses at 8.62% (up 0.4 percentage points) [2] Store Expansion and Brand Development - As of December 31, 2024, the group operated 2,126 independent retail stores globally, an increase of 101 stores since June 30, 2024, with JNBY having 960 stores [3] - The company upgraded store images and optimized supply chain management, contributing to retail performance improvement, alongside the acquisition of Hangzhou Muli Brand Management Company to expand its brand matrix [3] Future Outlook - The company is expected to achieve revenues of 5.53 billion, 5.96 billion, and 6.42 billion yuan for FY2025-2027, with net profits of 880 million, 930 million, and 1 billion yuan respectively, indicating a positive growth trajectory [4] - The current closing price corresponds to a PE ratio of 8.0, 7.5, and 7.0 for the respective years, suggesting the company is a low-valuation, high-dividend quality stock [4]

Core Viewpoint - The company reported stable growth in FY2025 H1, with a mid-term dividend of 0.45 HKD per share, and is expected to maintain its leading designer brand advantage in FY2025 H2, resulting in steady performance [1][2]. Financial Performance - In FY2025 H1, the company achieved revenue of 3.156 billion RMB, a year-on-year increase of 5.0%, and a net profit of 604 million RMB, up 5.5% year-on-year, meeting expectations [1]. - The company's gross margin remained stable during this period [1]. Brand Performance - The mature brand JNBY generated revenue of 1.76 billion RMB in H1, growing by 3.6% year-on-year, while emerging brands saw significant growth with a total revenue of 190 million RMB, up 147% year-on-year [2]. - The growth rates for other brands were as follows: Su Xie at 390 million RMB (-6.0%), jnby by JNBY at 480 million RMB (-0.6%), and LESS at 340 million RMB (+0.8%) [2]. Channel Performance - Revenue from self-operated, distribution, and online channels in H1 was 1.12 billion RMB (-7.7%), 1.44 billion RMB (+14.2%), and 600 million RMB (+11.9%) respectively [2]. - The company has a total of 491 self-operated stores and 1614 distribution stores in China, with a net decrease of 24 self-operated stores and a net increase of 126 distribution stores in H1 [2]. Membership and Consumer Engagement - Membership sales accounted for over 80% of total sales, with active members spending over 5000 RMB increasing to 330,000, contributing to a sales increase of 8% to 4.68 billion RMB [2]. - The company is focusing on enhancing brand strength and refining membership management for steady growth in FY2025 [2]. Dividend and Shareholder Returns - The company announced a mid-term dividend of 0.45 HKD per share, with an expected annual dividend yield of approximately 8% [2].